Changzhou Bairuiji Biomedical

Changzhou Bairuiji Biomedical is a Chinese medical technology company specializing in the development and manufacture of high-end absorbable biomaterials and medical devices. Founded in 2011 and based in Changzhou, the company focuses on surgical anti-adhesion, hemostasis, and advanced wound care solutions. Its core product line includes medical chitosan gels and absorbable hemostatic materials used across clinical departments such as obstetrics, gynecology, and general surgery. Bairuiji operates GMP-certified manufacturing facilities and maintains a strong R&D focus on regenerative medicine and tissue engineering. The company's products are designed to improve surgical outcomes by reducing postoperative complications and accelerating the healing process. Bairuiji has established a significant presence in the Chinese domestic market with multiple NMPA-approved Class III medical devices.